Ritonavir Completed Phase 4 Trials for Drug Drug Interaction (DDI) Basic Science

Indications	Status	Purpose	Phase
DBCOND0106607 (Drug Drug Interaction (DDI))	Completed	Basic Science	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04531072	Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine	Artemether (DB06697) Atazanavir (DB01072) Lumefantrine (DB06708) Ritonavir (DB00503)